Actively Recruiting
A Observational Study to Evaluate the Efficacy and Safety of Pacitol Inj.
Led by Boryung Pharmaceutical Co., Ltd · Updated on 2024-12-12
1000
Participants Needed
1
Research Sites
127 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate the efficacy and safety of pacitol Inj.(paricalcitol) for secondary hyperparathyroidism with stage 5D chronic kidney disease (CKD 5D) receiving hemodialysis
CONDITIONS
Official Title
A Observational Study to Evaluate the Efficacy and Safety of Pacitol Inj.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Hemodialysis patients with secondary hyperparathyroidism due to stage 5D chronic kidney disease scheduled to receive Pacitol Injection as per product information
- Voluntarily signed a written consent for personal information collection and study participation after explanation
- Able to understand the study, cooperate, and commit to completing the study
You will not qualify if you...
- History of hypersensitivity to Pacitol Injection or its components
- Evidence of vitamin D toxicity
- Hypercalcemia at enrollment
- Pregnant or lactating women
- Evidence of parathyroid adenoma scheduled for parathyroidectomy
- Participation in other clinical trials with investigational drugs within 12 weeks before baseline
- Judged ineligible by the principal or sub-investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
DongGuk university Ilsan hospital
Goyang-si, Gyeonggi-do, South Korea, 10326
Actively Recruiting
Research Team
S
Shinyoung Oh
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here